tiprankstipranks
Top Stocks
U.S. Stock Market OverviewTop Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
Top ETFs by AUMSPY ETFQQQ ETF
Stock Comparison
Energy StocksOil StocksBest Value StocksAirline StocksElectric Vehicle StocksMATANA Stocks
New
Bank StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
Global Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsPre-Market BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

Corona

Novavax: Street Underestimating Anticipated Strong Q2 and Outlook, Says Analyst
CoronaNovavax: Street Underestimating Anticipated Strong Q2 and Outlook, Says Analyst
6M ago
NVAX
Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In
CoronaIs Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In
11M ago
PFE
BNTX
Novavax: Rising Cases Could Lead to Faster Uptake of Covid-19 Vaccine
CoronaNovavax: Rising Cases Could Lead to Faster Uptake of Covid-19 Vaccine
11M ago
NVAX
Novavax: Covid-19 Vaccine Has Good Odds for EUA Approval, Says Analyst
CoronaNovavax: Covid-19 Vaccine Has Good Odds for EUA Approval, Says Analyst
11M ago
NVAX
Vaxart Stock: Awaiting Platform Validation for the Bull-Case to Kick In
CoronaVaxart Stock: Awaiting Platform Validation for the Bull-Case to Kick In
11M ago
VXRT
In Search of a Better Covid Vaccine, This Analyst Taps Ocugen
CoronaIn Search of a Better Covid Vaccine, This Analyst Taps Ocugen
1y ago
Novavax Stock Could Hit $315, Says Analyst
CoronaNovavax Stock Could Hit $315, Says Analyst
1y ago
Is Gritstone Stock a Buy Right Now? This Is What You Need to Know
CoronaIs Gritstone Stock a Buy Right Now? This Is What You Need to Know
1y ago
Is 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs In
CoronaIs 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs In
1y ago
Why This Analyst Sees Over 80% Upside Potential for Vaxart Stock
CoronaWhy This Analyst Sees Over 80% Upside Potential for Vaxart Stock
1y ago
VXRT
Moderna Stock Is Overvalued by 30%, Says JPMorgan
CoronaModerna Stock Is Overvalued by 30%, Says JPMorgan
1y ago
Novavax: Analysts Applaud the Latest Developments
CoronaNovavax: Analysts Applaud the Latest Developments
1y ago
Ocugen’s Covid-19 Vaccine Might Have One up on mRNA Vaccines
CoronaOcugen’s Covid-19 Vaccine Might Have One up on mRNA Vaccines
1y ago
Pfizer Vaccine Less Effective on Omicron in South Africa
CoronaPfizer Vaccine Less Effective on Omicron in South Africa
1y ago
NASDAQ
Moderna: Too Early to Tell Whether Flu Vaccine Has Differentiating Features
CoronaModerna: Too Early to Tell Whether Flu Vaccine Has Differentiating Features
1y ago
Moderna Accelerates COVID-19 Vaccine Supply to COVAX
CoronaModerna Accelerates COVID-19 Vaccine Supply to COVAX
1y ago
NASDAQ
Moderna Stock Dips Again; Valuation Remains Steep
CoronaModerna Stock Dips Again; Valuation Remains Steep
1y ago
NASDAQ
AstraZeneca Lands FDA Authorization; What Next?
CoronaAstraZeneca Lands FDA Authorization; What Next?
1y ago
NASDAQ
Moderna Takes a Hit Against Omicron
CoronaModerna Takes a Hit Against Omicron
1y ago
NASDAQ
Moderna to Supply Additional COVID-19 Vaccines to the UK
CoronaModerna to Supply Additional COVID-19 Vaccines to the UK
1y ago
NASDAQ
Novavax: Covid-19 Vaccine’s Rollout Could Play Part in Combating Omicron Variant
CoronaNovavax: Covid-19 Vaccine’s Rollout Could Play Part in Combating Omicron Variant
1y ago
Ocugen: IND Halt Not a Concern for Covaxin, Says Analyst
CoronaOcugen: IND Halt Not a Concern for Covaxin, Says Analyst
1y ago
Moderna: The Best Covid-19 Vaccine Maker Around, Says Analyst
CoronaModerna: The Best Covid-19 Vaccine Maker Around, Says Analyst
1y ago
Pfizer: Shares Are Overvalued but the Developing Covid Story Remains a Catalyst
CoronaPfizer: Shares Are Overvalued but the Developing Covid Story Remains a Catalyst
1y ago
NASDAQ
Novavax: Covid-19 Vaccine Gathering Momentum
CoronaNovavax: Covid-19 Vaccine Gathering Momentum
1y ago
Moderna: What You Need to Know Right Now
CoronaModerna: What You Need to Know Right Now
1y ago
Inovio Stock at $35 a Share? This Analyst Thinks It’s Possible
CoronaInovio Stock at $35 a Share? This Analyst Thinks It’s Possible
1y ago
Ocugen: What You Need to Know Right Now
CoronaOcugen: What You Need to Know Right Now
1y ago
Sorrento: Covid-19 Tests Could Generate Significant Revenue, Says Analyst
CoronaSorrento: Covid-19 Tests Could Generate Significant Revenue, Says Analyst
1y ago